2006•Di-Si Junyi Daxue xuebaoRequires access

Assessment of pharmacokinetics and bioequivalence of amlodipine besylate in healthy volunteers

Yan Zhang

Open publisher page 0 citations

Abstract

AIM: To study the pharmacokinetics parameters and bioavailability of amlodipine besylate tablets.METHODS: An open,randomized and two-period crossover study with a two-week washout interval was performed in 18 healthy volunteers.Concentrations of amlodipine besylate in plasma were assayed by liquid chromatographic-mass-mass spectrometric method after a single(oral) dose of 10 mg of the tested or the referenced tablets. The pharmacokinetics parameters,AUC,T_(max) and C_(max) were analyzed by two one-side t test and(1-2α) 90%.RESULTS: The main pharmacokinetics of the tested and referenced tablets were: T_(max):(8.9±2.5) and(8.2±2.2) h;C_(max):(5.1±2.3) and((5.0±)2.2) g/L;T_(1/2):(45±10) and(48±24) h;AUC_((0-120 h)):(191±69) and(196±53) μg/(L·h).The relative bioavailiability of amlodipine besylate was(99±23)%.(CONCLUSION:) The results of the statistical analysis show that the two formulations are bioequivalent.

About this research paper

What this paper is about

AIM: To study the pharmacokinetics parameters and bioavailability of amlodipine besylate tablets.METHODS: An open,randomized and two-period crossover study with a two-week washout interval was performed in 18 healthy volunteers.Concentrations of amlodipine besylate in plasma were assayed by liquid chromatographic-mass-mass spectrometric method after a single(oral) dose of 10 mg of the tested or the referenced tablets. The pharmacokinetics parameters,AUC,T_(max) and C_(max) were analyzed by two one-side t test and(1-2α) 90%.RESULTS: The main pharmacokinetics of the tested and referenced tablets were: T_(max):(8.9±2.5) and(8.2±2.2) h;C_(max):(5.1±2.3) and((5.0±)2.2) g/L;T_(1/2):(45±10) and(48±24) h;AUC_((0-120 h)):(191±69) and(196±53) μg/(L·h).The relative bioavailiability of amlodipine besylate was(99±23)%.(CONCLUSION:) The results of the statistical analysis show that the two formulations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To study the pharmacokinetics parameters and bioavailability of amlodipine besylate tablets.METHODS: An open,randomized and two-period crossover study with a two-week washout interval was performed in 18 healthy volunteers.Concentrations of amlodipine besylate in plasma were assayed by liquid chromatographic-mass-mass spectrometric method after a single(oral) dose of 10 mg of the tested or the referenced tablets. The pharmacokinetics parameters,AUC,T_(max) and C_(max) were analyzed by two one-side t test and(1-2α) 90%.RESULTS: The main pharmacokinetics of the tested and referenced tablets were: T_(max):(8.9±2.5) and(8.2±2.2) h;C_(max):(5.1±2.3) and((5.0±)2.2) g/L;T_(1/2):(45±10) and(48±24) h;AUC_((0-120 h)):(191±69) and(196±53) μg/(L·h).The relative bioavailiability of amlodipine besylate was(99±23)%.(CONCLUSION:) The results of the statistical analysis show that the two formulations are bioequivalent.

Key concepts: Bioequivalence, Pharmacokinetics, Amlodipine, Bioavailability, Crossover study, Pharmacology, Plasma concentration, Chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Assessment of pharmacokinetics and bioequivalence of amlodipine besylate in healthy volunteers — Research Paper | ScholarLens